Sheila Jacobs

Does mild to moderate COVID-19 have a negative long-term effect on lung function in young adults, and does having asthma or allergies make a difference in the effect?

Researchers reported on the severity of COVID-19 outcomes in patients with psoriatic disease, using data from the WARCOV study.

A study examining hemodynamically guided management of patients with chronic HF found significant changes in clinical outcomes during the COVID-19 pandemic.

How often do survivors of severe COVID-19 pulmonary infection experience long-term exercise capacity limitation, and what factors are associated with this condition?

In a review, researchers evaluated any otologic manifestation following vaccine administration and investigated the potential pathophysiology, clinical approach, and treatment.

In patients with severe pneumonia, how do clinical characteristics, comorbidities, and mortality rates differ between those with vs without COVID-19?

What risk factors affect ESBL-producing bacterial infection, and what factors are associated with its prognosis and with its resistance to antibiotics?

Researchers examined characteristics associated with critical COVID-19 illness among patients with congenital heart defects.

In a cross-sectional, population-based analysis, researchers examined the potential link between COVID-19 vaccination and the occurrence of sudden sensorineural hearing loss.

Researchers analyzed the rates of successful smoking cessation in US adults with vs without chronic obstructive pulmonary disease.

Researchers examined the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine and a third dose of mRNA-1273 vaccine booster concomitantly.

The association between DMARD interruption and RA disease activity during COVID-19 vaccination was determined.

Do immunocompromised individuals produce antibodies after receipt of an RNA-based COVID-19 vaccination?

Researchers assess the impact of DMARD combinations and monotherapy on immune response to the COVID-19 vaccine in patients with rheumatoid arthritis.

What outcomes are associated with compassionate use of amikacin liposome inhalation suspension for patients with Mycobacterium abscessus pulmonary disease?

Researchers sought to determine the impact of the COVID-19 pandemic on developmental service delivery among children with a history of neonatal seizures.

Researchers assessed the immunomodulatory activity of bacteria in the lung microbiota, which led to a closer analysis on R mucilaginosa’s anti-inflammatory effect.

Researchers sought to examine the associations between maternal SARS-CoV-2 infection during pregnancy, being born during the COVID-19 pandemic regardless of in utero COVID-19 exposure, and neurodevelopmental status at 6 months.

In a retrospective analysis, researchers assessed blood biomarkers of neurodegeneration in patients hospitalized for COVID-19 without a history of dementia.

How does methylprednisolone dose and duration affect rates of VTE and mortality among patients with COVID-19 pneumonia?

Researchers sought to assess whether COVID-19 infection developed despite of vaccination among patients with multiple sclerosis or neuromyelitis optica spectrum disorder, using a French database of these patient populations.

Do patients who receive treatment with long-term immunosuppressive medications have worse outcomes when hospitalized with COVID-19?

A meta-analysis looked at the safety and mortality benefit of using CPAP for managing pediatric respiratory infections in low- and middle-income countries.

Will there be a post-pandemic re-emergence of RSV? A simulation model shows clinicians and hospitals need to be prepared for atypical RSV outbreaks.

A phase 3 clinical trial evaluated the monoclonal antibody lenzilumab for improving survival without mechanical ventilation in COVID-19 pneumonia.

Researchers studied the impact of the COVID-19 pandemic on the presentation of juvenile idiopathic arthritis and related JIA research in Canada.

The COVIDSTEROID2 trial assessed the effects of varying doses of dexamethasone —12mg/day vs 6mg/day — in patients with COVID-19 and severe hypoxemia.

What effect does doxycycline have on patients with COVID-19 pneumonia?

Are patients with common variable immunodeficiency at higher risk of adverse outcomes from COVID-19?

A study examines the accuracy of pulse oximetry measures for various racial and ethnic subgroups, and how variability among subgroups affects outcomes.